Literature DB >> 17242277

Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.

Makoto Sahara1, Masataka Sata, Toshihiro Morita, Kazuto Nakamura, Yasunobu Hirata, Ryozo Nagai.   

Abstract

BACKGROUND: Recent evidence suggests that bone marrow (BM)-derived cells may differentiate into vascular cells that participate in arterial repair and/or lesion formation. However, it remains uncertain whether BM-derived cells also can participate in vascular remodeling associated with pulmonary arterial hypertension. METHODS AND
RESULTS: The BM of Sprague-Dawley rats was reconstituted with that of green fluorescent protein-transgenic rats. The BM-chimeric rats were injected intraperitoneally with 60 mg/kg monocrotaline after unilateral subpneumonectomy, and they concurrently underwent wire-mediated endovascular injury in femoral artery. After 28 days, they had elevated right ventricular systolic pressure (58.8+/-5.4 versus 20.4+/-2.4 mm Hg in sham-control; P<0.01). The pulmonary arterioles were markedly thickened, with an infiltration of green fluorescent protein-positive macrophages into the perivascular areas. The endothelium of pulmonary arterioles contained only a few green fluorescent protein-positive cells, and green fluorescent protein-positive cells were seldom detected as smooth muscle cells in the lesions of thickened pulmonary arterioles. In contrast, BM-derived smooth muscle-like cells could be readily detected in the thickened neointima and media of the wire-injured femoral artery. Moreover, intravenous injection of 1x10(8) BM cells from young rats had no beneficial effects on pulmonary hypertension, pulmonary arterial remodeling, or survival in the aged rats treated with monocrotaline plus unilateral subpneumonectomy. No injected BM cell was identified as an endothelial cell or a smooth muscle cell.
CONCLUSIONS: These results suggest that BM-derived cells can participate in arterial neointimal formation after mechanical injury, whereas they do not contribute substantially to pulmonary arterial remodeling associated with monocrotaline-induced pulmonary arterial hypertension in the pneumonectomized rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242277     DOI: 10.1161/CIRCULATIONAHA.106.655837

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

1.  Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

Authors:  Eleni Vergadi; Mun Seog Chang; Changjin Lee; Olin D Liang; Xianlan Liu; Angeles Fernandez-Gonzalez; S Alex Mitsialis; Stella Kourembanas
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Varicella zoster virus vasculopathy: analysis of virus-infected arteries.

Authors:  M A Nagel; I Traktinskiy; Y Azarkh; B Kleinschmidt-DeMasters; T Hedley-Whyte; A Russman; E M VanEgmond; K Stenmark; M Frid; R Mahalingam; M Wellish; A Choe; R Cordery-Cotter; R J Cohrs; D Gilden
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

Review 3.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

4.  The cancer paradigm of severe pulmonary arterial hypertension.

Authors:  Pradeep R Rai; Carlyne D Cool; Judy A C King; Troy Stevens; Nana Burns; Robert A Winn; Michael Kasper; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

5.  CD34+ progenitor to endothelial cell transition in post-pneumonectomy angiogenesis.

Authors:  Kenji Chamoto; Barry C Gibney; Grace S Lee; Miao Lin; Dinee Collings-Simpson; Robert Voswinckel; Moritz A Konerding; Akira Tsuda; Steven J Mentzer
Journal:  Am J Respir Cell Mol Biol       Date:  2011-09-15       Impact factor: 6.914

6.  Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension.

Authors:  Harry Karmouty-Quintana; Kemly Philip; Luis F Acero; Ning-Yuan Chen; Tingting Weng; Jose G Molina; Fayong Luo; Jonathan Davies; Ngoc-Bao Le; Isabelle Bunge; Kelly A Volcik; Thanh-Thuy T Le; Richard A Johnston; Yang Xia; Holger K Eltzschig; Michael R Blackburn
Journal:  FASEB J       Date:  2014-10-15       Impact factor: 5.191

7.  Reactive oxygen species effect PASMCs apoptosis via regulation of dynamin-related protein 1 in hypoxic pulmonary hypertension.

Authors:  Lixin Zhang; Cui Ma; Chen Zhang; Mingfei Ma; Fengying Zhang; Linlin Zhang; Yingli Chen; Fangyuan Cao; Shuzhen Li; Daling Zhu
Journal:  Histochem Cell Biol       Date:  2016-03-24       Impact factor: 4.304

Review 8.  Novel approaches to treat experimental pulmonary arterial hypertension: a review.

Authors:  S Umar; P Steendijk; D L Ypey; D E Atsma; E E van der Wall; M J Schalij; A van der Laarse
Journal:  J Biomed Biotechnol       Date:  2010-03-22

9.  Bone marrow-derived Kruppel-like factor 10 controls reendothelialization in response to arterial injury.

Authors:  Akm Khyrul Wara; Andre Manica; Julio F Marchini; Xinghui Sun; Basak Icli; Yevgenia Tesmenitsky; Kevin Croce; Mark W Feinberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-16       Impact factor: 8.311

10.  Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction.

Authors:  Tashera E Perry; Minjung Song; Daryl J Despres; Soo Mi Kim; Hong San; Zu-Xi Yu; Nalini Raghavachari; Jurgen Schnermann; Richard O Cannon; Donald Orlic
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.